Bhringaraj (Eclipta prostrata)

Bhringaraj (Eclipta prostrata) is an Ayurvedic herb whose primary bioactive compounds, wedelolactone and ecliptasaponins, drive its pharmacological effects. Wedelolactone inhibits NF-κB signaling and promotes hair follicle transition from telogen to anagen phase, underpinning its traditional use for hair and liver support.

Origin & History

Bhringaraj (Eclipta prostrata) is a perennial herbaceous plant native to tropical and subtropical regions, commonly found in moist areas throughout India. The whole plant, including leaves, stems, and roots, is extracted using solvents like ethanol, methanol, or water to yield bioactive compounds.

Historical & Cultural Context

In Ayurveda, Bhringaraj has been used for centuries to balance doshas and promote hair growth, luster, softness, and strength. The herb contains vitamins E and D plus minerals like calcium, magnesium, and iron, and has been traditionally applied both topically and orally for hair health.

Health Benefits

• Hair growth promotion supported by animal studies showing anagen phase induction in telogen follicles (preliminary evidence)
• Antioxidant activity demonstrated in vitro with dose-dependent ferricyanide reduction (IC50 100 µg/mL) (preliminary evidence)
• Antibacterial effects against E. coli, Bacillus sp., and Streptococcus in methanolic extract studies (preliminary evidence)
• Traditional use for preventing premature graying and hair loss in Ayurvedic medicine (traditional evidence only)
• Anti-venom properties for scorpion stings as used by tribal communities in India (traditional evidence only)

How It Works

Wedelolactone, a coumestan compound in Eclipta prostrata, inhibits IκB kinase (IKK), thereby suppressing NF-κB-mediated inflammatory cytokine transcription and reducing oxidative stress at the cellular level. Ethanolic leaf extracts stimulate dermal papilla cells and induce anagen-phase gene expression, potentially through upregulation of β-catenin and Sonic Hedgehog (Shh) signaling pathways in hair follicles. Ecliptasaponins and polyacetylenic thiophene derivatives further contribute to hepatoprotection by modulating cytochrome P450 enzyme activity and scavenging reactive oxygen species via the ferricyanide reduction pathway (IC50 ~100 µg/mL in vitro).

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified in the research dossier. Available evidence consists solely of preclinical studies including in vitro antioxidant assays and animal models for hair growth promotion.

Clinical Summary

Most evidence for Bhringaraj derives from in vitro assays and rodent models rather than rigorous human trials. A notable animal study demonstrated that topical Eclipta prostrata extract induced anagen phase in shaved telogen follicles of albino mice, with hair growth promotion comparable to 2% minoxidil in some parameters. Antibacterial activity against E. coli and Bacillus species has been confirmed in disc-diffusion assays, though minimum inhibitory concentrations vary widely by extract preparation. No large-scale randomized controlled trials in humans have been published to date, meaning all clinical claims remain preliminary and extrapolation from animal data should be made cautiously.

Nutritional Profile

Bhringaraj (Eclipta prostrata) is a medicinal herb rather than a dietary staple, so macronutrient content is not extensively characterized for nutritional purposes. Bioactive compounds are the primary focus of its profile. Key constituents include: Wedelolactone (a coumestan compound, approximately 0.1–0.5% dry weight in leaf extracts) — the principal bioactive marker compound; Ecliptine and related alkaloids (including nicotine derivatives at trace levels); Triterpene saponins including oleanolic acid and ursolic acid (combined ~0.3–1.2% dry weight); Flavonoids including luteolin, apigenin, and their glycosides (total flavonoid content reported at approximately 1.5–3.0 mg quercetin equivalents per gram dry extract in some studies); Coumestans beyond wedelolactone, including demethylwedelolactone; Phytosterols including beta-sitosterol and stigmasterol (trace to low mg/g range); Polyacetylenic thiophene derivatives unique to Eclipta species; Tannins and polyphenols contributing to antioxidant activity (total phenolic content ~15–40 mg gallic acid equivalents per gram dry extract reported in methanolic extracts); Eclalbatin (a thiophene glucoside). Regarding micronutrients: iron content has been noted in traditional contexts but precise mg/100g data is limited in peer-reviewed literature; calcium and phosphorus are present at moderate levels consistent with leafy herbs (~200–400 mg/100g dry weight estimated range). Crude fiber is present (~8–12% dry weight estimated, typical of herbaceous leaf material). Protein content is approximately 15–20% dry weight based on general herb composition data, though not specifically validated for Eclipta. Bioavailability notes: Wedelolactone demonstrates moderate oral bioavailability in rodent studies with hepatic first-pass metabolism; lipophilic compounds (sterols, triterpenes) have low aqueous solubility and benefit from oil-based or ethanolic preparations; traditional sesame oil-based preparations (as used in Ayurvedic hair oils) are consistent with enhancing absorption of fat-soluble actives. Water-soluble polyphenols are more bioavailable in aqueous decoctions.

Preparation & Dosage

No clinically studied dosage ranges are available due to absence of human trials. Preclinical studies used concentrations of 25-100 mg/mL for antioxidant assays. Traditional Ayurvedic use involves both topical application and oral consumption, but specific doses are not established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Amla, Brahmi, Ashwagandha, Neem, Coconut oil

Safety & Interactions

Bhringaraj is generally considered well-tolerated at traditional Ayurvedic doses (3–6 g dried herb daily), but systematic human safety data are lacking. Wedelolactone exhibits anti-coagulant properties in vitro, raising a theoretical interaction risk with anticoagulant or antiplatelet drugs such as warfarin and clopidogrel; concurrent use warrants medical supervision. Due to insufficient safety data, use during pregnancy and lactation is not recommended. Individuals with pre-existing liver conditions should consult a healthcare provider before use, as high-dose extracts have shown hepatotoxic effects in select animal models despite the herb's traditional hepatoprotective reputation.